Sienna Labs was selected to present at the 2nd Annual Dermatology Summit on January 11th, 2015 in San Francisco.

Sienna Labs is a leader in biophysics, with its patented plasmonic nanoparticle technology.

“We are honored to be selected to speak at this prestigious event and believe it is a testament to the paradigm shifting nature of our platform technology,” said Todd Harris, Chief Executive Officer of Sienna Labs.

The Dermatology Summit brings together business leaders from established and emerging companies in the dermatology space as well as members of the finance community to help foster investment and partnerships in the next generation of dermatology companies and products.